Medicare Enrolled
Dr. Prem Sahasranam, M.D.
Endocrinology · Hanford, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sahasranam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sahasranam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sahasranam
Dr. Prem Sahasranam is an endocrinology specialist in Hanford, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sahasranam performed 7,787 Medicare services across 3,037 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sahasranam received a total of $9,443 from 39 pharmaceutical and/or device companies across 569 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sahasranam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in CA
$9,443 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,787
Medicare services
Top 11% in CA for endocrinology
3,037
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~433 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,852 | $89 | $178 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,437 | $71 | $123 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
970 | $42 | $75 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
745 | $42 | $65 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
719 | $39 | $60 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
713 | $32 | $51 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
362 | $26 | $60 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
358 | $43 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
172 | $117 | $284 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
155 | $86 | $190 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
66 | $16 | $35 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
63 | $95 | $150 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
55 | $46 | $82 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
51 | $84 | $188 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
48 | $19 | $35 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
21 | $124 | $206 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,443
Total received (2018-2024)
Avg $1,349/year across 7 years
Top 21% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
569
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,276 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92 (1.0%)
Other
Charitable contributions, space rental, and other categories
$75 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$769
2023
$1,224
2022
$1,989
2021
$1,806
2020
$991
2019
$1,567
2018
$1,097
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$204
Xeris Pharmaceuticals, Inc.
$103
Radius Health, Inc.
$85
Abbott Laboratories
$75
Novartis Pharmaceuticals Corporation
$56
SANOFI-AVENTIS U.S. LLC
$34
Nevro Corp.
$33
Kyowa Kirin, Inc.
$29
ABBVIE INC.
$27
Medtronic, Inc.
$24
Ascendis Pharma Inc
$23
Amgen Inc.
$22
Mannkind Corporation
$21
Lilly USA, LLC
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,986
Novo Nordisk Inc
$1,085
AstraZeneca Pharmaceuticals LP
$942
Abbott Laboratories
$506
Esperion Therapeutics, Inc.
$438
Mannkind Corporation
$415
MannKind Corporation
$363
Lilly USA, LLC
$338
Insulet Corporation
$312
Boehringer Ingelheim Pharmaceuticals, Inc.
$301
SANOFI-AVENTIS U.S. LLC
$283
Xeris Pharmaceuticals, Inc.
$266
Radius Health, Inc.
$236
Dexcom, Inc.
$230
AbbVie, Inc.
$212
AbbVie Inc.
$181
Merck Sharp & Dohme Corporation
$147
Medtronic, Inc.
$126
ABBVIE INC.
$121
Becton, Dickinson and Company
$113
Tandem Diabetes Care, Inc.
$109
Kyowa Kirin, Inc.
$103
Novartis Pharmaceuticals Corporation
$84
Nevro Corp.
$79
Amarin Pharma Inc.
$73
Ultragenyx Pharmaceutical Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$52
Shire North American Group Inc
$48
DEXCOM, INC.
$41
Horizon Therapeutics plc
$39
Ascendis Pharma Inc
$23
CeQur Corporation
$21
Alexion Pharmaceuticals, Inc.
$20
Corcept Therapeutics
$19
Medtronic MiniMed, Inc.
$17
Senseonics, Incorporated
$16
Regeneron Healthcare Solutions, Inc.
$16
Medtronic Vascular, Inc.
$15
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Androgel · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE COPILOT · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MINIMED 780G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Omnia · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · Saxenda · Senza · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · Vascepa · VenaSeal · Victoza · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
4
Per 100K population
2.6
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sahasranam is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sahasranam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sahasranam performed 1,852 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sahasranam receive payments from pharmaceutical companies?
Yes. Dr. Sahasranam received a total of $9,443 from 39 companies across 569 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sahasranam's costs compare to other endocrinologists in Hanford?
Dr. Sahasranam's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sahasranam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Hanford
Browse endocrinologists in Hanford ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology